Cargando…

Molecular Targets of Naturopathy in Cancer Research: Bridge to Modern Medicine

The relevance of naturopathy (defined as the practice of medicine for the treatment of human diseases with natural agents) in human cancer is beginning to be appreciated, as documented by renewed interest in nutraceutical research, the natural anticancer agents of dietary origin. Because of their pl...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmad, Aamir, Ginnebaugh, Kevin R., Li, Yiwei, Padhye, Subhash B., Sarkar, Fazlul H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303842/
https://www.ncbi.nlm.nih.gov/pubmed/25569626
http://dx.doi.org/10.3390/nu7010321
_version_ 1782353983326650368
author Ahmad, Aamir
Ginnebaugh, Kevin R.
Li, Yiwei
Padhye, Subhash B.
Sarkar, Fazlul H.
author_facet Ahmad, Aamir
Ginnebaugh, Kevin R.
Li, Yiwei
Padhye, Subhash B.
Sarkar, Fazlul H.
author_sort Ahmad, Aamir
collection PubMed
description The relevance of naturopathy (defined as the practice of medicine for the treatment of human diseases with natural agents) in human cancer is beginning to be appreciated, as documented by renewed interest in nutraceutical research, the natural anticancer agents of dietary origin. Because of their pleiotropic effects and the ability to modulate multiple signaling pathways, which is a good attribute of natural agents, nutraceuticals have frequently been demonstrated to re-sensitize drug-resistant cancers. The effectiveness of nutraceuticals can be further enhanced if the tools for the relative assessment of their molecular targets are readily available. Such information can be critical for determining their most effective uses. Here, we discuss the anticancer potential of nutraceuticals and the associated challenges that have interfered with their translational potential as a naturopathic approach for the management of cancers. In the years to come, an efficient screening and assessment of molecular targets will be the key to make rapid progress in the area of drug design and discovery, especially focusing on evidence-based development of naturopathy for the treatment of human malignancies.
format Online
Article
Text
id pubmed-4303842
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-43038422015-02-02 Molecular Targets of Naturopathy in Cancer Research: Bridge to Modern Medicine Ahmad, Aamir Ginnebaugh, Kevin R. Li, Yiwei Padhye, Subhash B. Sarkar, Fazlul H. Nutrients Review The relevance of naturopathy (defined as the practice of medicine for the treatment of human diseases with natural agents) in human cancer is beginning to be appreciated, as documented by renewed interest in nutraceutical research, the natural anticancer agents of dietary origin. Because of their pleiotropic effects and the ability to modulate multiple signaling pathways, which is a good attribute of natural agents, nutraceuticals have frequently been demonstrated to re-sensitize drug-resistant cancers. The effectiveness of nutraceuticals can be further enhanced if the tools for the relative assessment of their molecular targets are readily available. Such information can be critical for determining their most effective uses. Here, we discuss the anticancer potential of nutraceuticals and the associated challenges that have interfered with their translational potential as a naturopathic approach for the management of cancers. In the years to come, an efficient screening and assessment of molecular targets will be the key to make rapid progress in the area of drug design and discovery, especially focusing on evidence-based development of naturopathy for the treatment of human malignancies. MDPI 2015-01-06 /pmc/articles/PMC4303842/ /pubmed/25569626 http://dx.doi.org/10.3390/nu7010321 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Ahmad, Aamir
Ginnebaugh, Kevin R.
Li, Yiwei
Padhye, Subhash B.
Sarkar, Fazlul H.
Molecular Targets of Naturopathy in Cancer Research: Bridge to Modern Medicine
title Molecular Targets of Naturopathy in Cancer Research: Bridge to Modern Medicine
title_full Molecular Targets of Naturopathy in Cancer Research: Bridge to Modern Medicine
title_fullStr Molecular Targets of Naturopathy in Cancer Research: Bridge to Modern Medicine
title_full_unstemmed Molecular Targets of Naturopathy in Cancer Research: Bridge to Modern Medicine
title_short Molecular Targets of Naturopathy in Cancer Research: Bridge to Modern Medicine
title_sort molecular targets of naturopathy in cancer research: bridge to modern medicine
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303842/
https://www.ncbi.nlm.nih.gov/pubmed/25569626
http://dx.doi.org/10.3390/nu7010321
work_keys_str_mv AT ahmadaamir moleculartargetsofnaturopathyincancerresearchbridgetomodernmedicine
AT ginnebaughkevinr moleculartargetsofnaturopathyincancerresearchbridgetomodernmedicine
AT liyiwei moleculartargetsofnaturopathyincancerresearchbridgetomodernmedicine
AT padhyesubhashb moleculartargetsofnaturopathyincancerresearchbridgetomodernmedicine
AT sarkarfazlulh moleculartargetsofnaturopathyincancerresearchbridgetomodernmedicine